Tonsillectomy. Hypertrophy of tonsils, Hypertrophy of tonsils with hypertrophy of adenoids
Conditions
Interventions
Intervention 1: Group 1-(Intervention Group): 10 ml of Bupivacaine 5 mg/ml in each site of operation-totally 20 ml- was injected before incision. After surgery, this group was also allowed to take ora
Treatment - Drugs
Group 1-(Intervention Group): 10 ml of Bupivacaine 5 mg/ml in each site of operation-totally 20 ml- was injected before incision. After surgery, this group was also allowed to take oral acetaminophen
Group 2-(Intervention Group): 10 ml of Bupivacaine 5 mg/ml in each site of operation-totally 20 ml- was injected after excision of tonsils. After surgery, this group was also allowed to take oral acet
Group 3-(Control Group): Bupivacaine injection was not used. After surgery, this group was also allowed to take oral acetaminophen (children less than 12 years: 10-15 mg/kg/dose, each 6 hours and chil
Sponsors
Vice Chancellor for Research, Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
3 Years to 15 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1) age range 3-15 years old; 2) patients who undergo tonsillectomy due to three or more severe recurrent attacks of tonsillitis within each two consecutive years. Exclusion criteria: 1) pre operative medical problems such as asthma, diabetes, coagulation disorders, cardiovascular disease, basic metabolic disorder, immune system deficiency and chronic liver or renal disease; 2) Inadequate follow-up and incomplete questionnaires.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Post-tonsillectomy pain. Timepoint: within 24 hours after operation. Method of measurement: Pain had been evaluated by Visual Analog Scale by trained anesthesia nurse in the ward. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSareh Roosta
Center for Development of Clinical Studies, Vice Chancellor of Research and Technology, Shiraz Unive
Outcome results
None listed